Compile Data Set for Download or QSAR
Found 129 with Last Name = 'byth' and Initial = 'kf'
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50263028(4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimi...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246447(2-fluoro-4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-im...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM7657(4-[(4-{imidazo[1,2-a]pyridin-3-yl}pyrimidin-2-yl)a...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246298(CHEMBL487067 | N-(2-hydroxyethyl)-4-(4-(1-isopropy...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246350(4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246301(4-(4-(1-cyclopentyl-2-methyl-1H-imidazol-5-yl)pyri...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7667(4-[(4-{6-bromoimidazo[1,2-a]pyridin-3-yl}pyrimidin...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7668(4-[(4-{6-cyanoimidazo[1,2-a]pyridin-3-yl}pyrimidin...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7669(4-({4-[6-(ethylsulfanyl)imidazo[1,2-a]pyridin-3-yl...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7671(4-[(4-{imidazo[1,2-a]pyridazin-3-yl}pyrimidin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7672(4-[(4-{imidazo[1,2-a]pyridazin-3-yl}pyrimidin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7673(4-[(4-{imidazo[1,2-a]pyridazin-3-yl}pyrimidin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7675(Imidazo[1,2-b]pyridazine deriv. 2e | N-[3-(dimethy...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7679(Imidazo[1,2-b]pyridazine deriv. 4b | N-(2-methoxye...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50025069(CHEMBL485425)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50025068(CHEMBL484555)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM7672(4-[(4-{imidazo[1,2-a]pyridazin-3-yl}pyrimidin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7665(4-[(5-bromo-4-{imidazo[1,2-a]pyridin-3-yl}pyrimidi...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7664(4-[(5-chloro-4-{imidazo[1,2-a]pyridin-3-yl}pyrimid...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7658(4-[(4-{imidazo[1,2-a]pyridin-3-yl}pyrimidin-2-yl)a...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7655(4-{imidazo[1,2-a]pyridin-3-yl}-N-phenylpyrimidin-2...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7647(4-[(4-{2-methylimidazo[1,2-a]pyridin-3-yl}pyrimidi...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2610XJ5PubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7657(4-[(4-{imidazo[1,2-a]pyridin-3-yl}pyrimidin-2-yl)a...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7662(N-[3-(dimethylamino)propyl]-4-[(4-{imidazo[1,2-a]p...)copy SMILEScopy InChI
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246349(4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246255(4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimi...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246254(4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimi...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7660(4-[(4-{imidazo[1,2-a]pyridin-3-yl}pyrimidin-2-yl)a...)copy SMILEScopy InChI
Affinity DataIC50: 4nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50274698(4-(4-(1-ethyl-2-methyl-1H-imidazol-5-yl)pyrimidin-...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7663(N-[3-(dimethylamino)propyl]-4-[(4-{imidazo[1,2-a]p...)copy SMILEScopy InChI
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7656(Imidazo[1,2-a]pyridine deriv. 1g | N-(3-chlorophen...)copy SMILEScopy InChI
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7661(N-[2-(dimethylamino)ethyl]-4-[(4-{imidazo[1,2-a]py...)copy SMILEScopy InChI
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246397(2-fluoro-4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-...)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7649(2,4-bisanilinopyrimidine deriv. 9 | 4-({4-[(2-fluo...)copy SMILEScopy InChI
Affinity DataIC50: 6nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2610XJ5PubMed
TargetG1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246253(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(me...)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Inhibition of Cyclin E/CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50274662(4-(4-(1,2-dimethyl-1H-imidazol-5-yl)pyrimidin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246253(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(me...)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7674(CHEMBL484571 | Imidazo[1,2-b]pyridazine deriv. 2d ...)copy SMILEScopy InChI
Affinity DataIC50: 8nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM7674(CHEMBL484571 | Imidazo[1,2-b]pyridazine deriv. 2d ...)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50274661(4-(4-(1,2-dimethyl-1H-imidazol-5-yl)pyrimidin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50274625(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(pr...)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246256(4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimi...)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50246448(4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-...)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23N2377PubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50274626(4-(4-(1,2-dimethyl-1H-imidazol-5-yl)pyrimidin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM7659(4-[(4-{imidazo[1,2-a]pyridin-3-yl}pyrimidin-2-yl)a...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7659(4-[(4-{imidazo[1,2-a]pyridin-3-yl}pyrimidin-2-yl)a...)copy SMILEScopy InChI
Affinity DataIC50: 12nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q22805TTPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50274806(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-((t...)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50274805(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(2-...)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50274699(4-(4-(1-isobutyl-2-methyl-1H-imidazol-5-yl)pyrimid...)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:Inhibition of CDK2More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2J9667KPubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Homo sapiens (Human))
AstraZeneca

LigandPNGBDBM7670(Imidazo[1,2-a]pyridine deriv. 4g | N-(2-methoxyeth...)copy SMILEScopy InChI
Affinity DataIC50: 16nMpH: 7.0 T: 2°CAssay Description:The kinase activity was assayed using an in vitro scintillation proximity assay (SPA) for measuring incorporation of [gamma-33P] ATP into GST-Rb.More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XG9PCFPubMed
Displayed 1 to 50 (of 129 total ) | Next | Last >>
Jump to: